How much revenue does RPG Life Sciences make?

RPG Life Sciences reported 6.53 billion INR in revenue for fiscal year 2025, up 12.3% from 5.82 billion INR in fiscal year 2024. In Q3 2026 revenue was 1.80 billion INR.

Where does RPG Life Sciences make most of its revenue?

India: 65% of revenue by region in fiscal year 2025, followed by Outside India (35%).

What companies are similar to RPG Life Sciences?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Sun Pharma Advanced Research Company Limited (SPARC.NS), FDC Limited (FDC.NS), Novartis India Limited (NOVARTIND.BO), Gufic Biosciences Limited (GUFICBIO.NS).

RPG Life Sciences Limited (RPGLIFE.NS) Stock

About RPG Life Sciences Limited

RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmintics, anti-convulsant, anti-spasmodic, etc. I...

At a glance

RPG Life Sciences reported revenue of 6.53 billion INR for fiscal year 2025, up 12.3% from fiscal year 2024, and net income of 1.83 billion INR. In Q3 2026 (the quarter ended December 31, 2025) revenue was 1.80 billion INR, up 4.2% from a year before. India was its largest region in fiscal year 2025, with 65% of revenue.

Figures from company filings; latest fiscal year ended March 31, 2025.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.